| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADA
|
adenosine deaminase
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKR1D1
|
aldo-keto reductase family 1, member D1
|
|
ALB
|
albumin
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMH
|
anti-Mullerian hormone
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
ARSA
|
arylsulfatase A
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASPA
|
aspartoacylase
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
CA2
|
carbonic anhydrase II
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCR
|
calcitonin receptor
|
|
CALR
|
calreticulin
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNB1
|
cyclin B1
|
|
CD38
|
CD38 molecule
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD53
|
CD53 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CKB
|
creatine kinase, brain
|
|
CKM
|
creatine kinase, muscle
|
|
CKS2
|
CDC28 protein kinase regulatory subunit 2
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSH
|
cathepsin H
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
ECM1
|
extracellular matrix protein 1
|
|
EDN1
|
endothelin 1
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FHIT
|
fragile histidine triad
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FST
|
follistatin
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAST
|
gastrin
|
|
GCG
|
glucagon
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRN
|
granulin
|
|
GSR
|
glutathione reductase
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HDAC9
|
histone deacetylase 9
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HMOX1
|
heme oxygenase 1
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HPSE
|
heparanase
|
|
HS3ST2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
IL9
|
interleukin 9
|
|
INS
|
insulin
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT8
|
keratin 8, type II
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
MAPT
|
microtubule-associated protein tau
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR125A
|
microRNA 125a
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR21
|
microRNA 21
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NBR1
|
neighbor of BRCA1 gene 1
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NELFE
|
negative elongation factor complex member E
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NMB
|
neuromedin B
|
|
NOX4
|
NADPH oxidase 4
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPY
|
neuropeptide Y
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
OCA2
|
oculocutaneous albinism II
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PF4
|
platelet factor 4
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PNLIP
|
pancreatic lipase
|
|
POMC
|
proopiomelanocortin
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRL
|
prolactin
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT6
|
protein arginine methyltransferase 6
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYY
|
peptide YY
|
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
|
RBM4
|
RNA binding motif protein 4
|
|
RBMY1A1
|
RNA binding motif protein, Y-linked, family 1, member A1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RETN
|
resistin
|
|
RORA
|
RAR-related orphan receptor A
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100B
|
S100 calcium binding protein B
|
|
SAA1
|
serum amyloid A1
|
|
SCG2
|
secretogranin II
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMG1
|
semenogelin I
|
|
SEMG2
|
semenogelin II
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SFTPB
|
surfactant protein B
|
|
SFTPD
|
surfactant protein D
|
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOST
|
sclerostin
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
ST2
|
suppression of tumorigenicity 2
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STX1A
|
syntaxin 1A (brain)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TF
|
transferrin
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
THBD
|
thrombomodulin
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTR
|
transthyretin
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A3
|
UDP glucuronosyltransferase 1 family, polypeptide A3
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
UGT2A1
|
UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
VCL
|
vinculin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WDR1
|
WD repeat domain 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
ZYX
|
zyxin
|
